Sign in
Companies / REGN / Total Debt

Regeneron Pharmaceuticals (REGN) Total Debt

2010–2025 · Annual, from company filings

Regeneron Pharmaceuticals (REGN) reported debt of $2.7B in fiscal 2025. Since fiscal 2021 ($2.7B), it has grown 0%.

1011121314151920213223233243253
Free: last 5 years
Fiscal yearFY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2015 🔒FY2019 🔒FY2020 🔒FY2021FY2022FY2023FY2024FY2025
Total Debt••••••••••••••••••••••••••••••••••••••••$2.7B$2.7B$2.7B$2.7B$2.7B

8 older years and all quarters are in Pro.

More on REGN

Related companies